These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35128522)

  • 1. Patient Involvement in the Health Technology Assessment Process in Taiwan.
    Chen KA; Huang LY; Gau CS
    Front Med Technol; 2021; 3():732160. PubMed ID: 35128522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Drug Reimbursement and Pricing Policy in Taiwan.
    Chen GT; Chang SC; Chang CJ
    Value Health Reg Issues; 2018 May; 15():127-132. PubMed ID: 29704659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the Impact of the Current Reimbursement Regulation on Patient Access to Innovative Medical Devices in Taiwan: Insights From 8 Years' Reimbursement Data.
    Peng JY; Lee SS; Lin CR; Lee H; Chen YC
    Value Health Reg Issues; 2024 Jul; 42():100978. PubMed ID: 38350187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient advocate perspectives on involvement in HTA: an international snapshot.
    Scott AM; Wale JL;
    Res Involv Engagem; 2017; 3():2. PubMed ID: 29062527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and Impacts of 10-Year HTA Implementation in Taiwan.
    Kao KL; Huang LY; Wu YH; Gau CS
    Int J Technol Assess Health Care; 2019; 35(6):441-445. PubMed ID: 30813980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient advocacy group involvement in health technology assessments: an observational study.
    Single A; Cabrera A; Fifer S; Tsai J; Paik JY; Hope P
    Res Involv Engagem; 2021 Nov; 7(1):83. PubMed ID: 34823610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment.
    Hunter A; Facey K; Thomas V; Haerry D; Warner K; Klingmann I; May M; See W
    Front Med (Lausanne); 2018; 5():231. PubMed ID: 30238004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies.
    Wale JL; Sullivan M
    Int J Technol Assess Health Care; 2020 Jun; 36(3):197-203. PubMed ID: 32375904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries.
    Dimitrova M; Jakab I; Mitkova Z; Kamusheva M; Tachkov K; Nemeth B; Zemplenyi A; Dawoud D; Delnoij DMJ; Houýez F; Kalo Z
    Front Public Health; 2022; 10():922708. PubMed ID: 35968493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International comparison of comparative effectiveness research in five jurisdictions: insights for the US.
    Levy AR; Mitton C; Johnston KM; Harrigan B; Briggs AH
    Pharmacoeconomics; 2010; 28(10):813-30. PubMed ID: 20831289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a decisional flowchart for meaningful patient involvement in Health Technology Assessment.
    Toledo-Chávarri A; Gagnon MP; Álvarez-Pérez Y; Perestelo-Pérez L; Triñanes Pego Y; Serrano Aguilar P;
    Int J Technol Assess Health Care; 2020 Dec; 37():e3. PubMed ID: 33267914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of patient involvement in health technology assessments: A scoping review.
    Mason RJ; Searle KM; Bombard Y; Rahmadian A; Chambers A; Mai H; Morrison M; Chan KKW; Jerzak KJ
    Int J Technol Assess Health Care; 2020 Jun; 36(3):217-223. PubMed ID: 32383420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patient participation in the assessment of alternatives to restraint and seclusion].
    Dipankui MT; Gagnon MP; Desmartis M; Legare F; Piron F; Gagnon J; Rhainds M; Coulombe M
    Sante Publique; 2014; 26(2):217-26. PubMed ID: 25108963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment.
    Elvsaas IKØ; Ettinger S; Willemsen A
    Int J Technol Assess Health Care; 2021 Jan; 37():e24. PubMed ID: 33468275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a parent advisory group to inform a research program for knowledge translation in child health.
    Hartling L; Elliott SA; Buckreus K; Leung J; Scott SD
    Res Involv Engagem; 2021 Jun; 7(1):38. PubMed ID: 34099069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patient involvement in a health technology assessment.
    Dipankui MT; Gagnon MP; Desmartis M; Légaré F; Piron F; Gagnon J; Rhiands M; Coulombe M
    Int J Technol Assess Health Care; 2015 Jan; 31(3):166-70. PubMed ID: 26062904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.